(Q57904265)

English

Appraising myc involvement in high risk myeloma

No description defined

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Appraising myc involvement in high risk myeloma (English)

0 references

Efstathios Kastritis

1

0 references

Athanasios Dimopoulos

series ordinal

2

object named as

Meletios A. Dimopoulos

0 references

publication date

5 November 2014

0 references

published in

Leukemia & Lymphoma

0 references

volume

56

0 references

issue

3

0 references

page(s)

551-552

0 references

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.961015

retrieved

21 January 2018

Molecular pathogenesis and a consequent classification of multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2014.961015

retrieved

21 January 2018

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2014.961015

retrieved

21 January 2018

Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2014.961015

retrieved

21 January 2018

Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2014.961015

retrieved

21 January 2018

Chromosome 8q24.1/c-MYC abnormality: a marker for high-risk myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2014.961015

retrieved

21 January 2018

Addiction to c-MYC in multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2014.961015

retrieved

21 January 2018

MYC addiction: a potential therapeutic target in MM.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2014.961015

retrieved

21 January 2018

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2014.961015

retrieved

21 January 2018

Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2014.961015

retrieved

21 January 2018

Identifiers

DOI

10.3109/10428194.2014.961015

0 references

PubMed ID

25257347

0 references

(Q57904265)

Appraising myc involvement in high risk myeloma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)